Nature’s Toolbox, Inc. (NTx), a life science company developing domestically-sourced biomanufacturing solutions for the delivery of personalized therapeutics and biologics, announced it secured $15...
Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, announced that it has entered into an agreement...
Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal,...
Ionpath, a leader in high-definition spatial proteomics, announced the launch of MIBIslide Blue, a groundbreaking advancement in multimodal imaging. Featuring a proprietary optically transparent...
Ipsen and Biomunex Pharmaceuticals announced an exclusive global licensing agreement for BMX-502. BMX-502 is a bispecific antibody that engages and activates a subset of...
